Lung Cancer Europe – A major new lung cancer advocacy tool launches today!
Lung Cancer Europe posted on LinkedIn:
“A major new lung cancer advocacy tool launches today!
Too many people still face delays and barriers to lung cancer treatment.
Lung Cancer Europe has created the Access to Treatment Atlas to show where and how access to treatment varies across Europe.
Built with and for patient advocates and other stakeholders, the Atlas brings together detailed information from over 30 countries on reimbursement and access to lung cancer treatments and diagnostics in a form of an interacive map.
The website is also a source of information about licensed treatments in Europe as well as biomarker testing.
It’s designed to support the work of advocates across Europe as well as other stakeholders – helping shape strategies to improve equity, push for change, and ultimately make sure where you live doesn’t decide the care you get.
Explore the Atlas.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023